Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
1.330
+0.120 (9.92%)
At close: Nov 4, 2026, 4:00 PM EST
1.330
0.00 (0.00%)
After-hours: Nov 4, 2026, 5:20 PM EST

Akso Health Group Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Nov '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
1,1391,95390595546842539017812017017
Market Cap Growth (YoY)
27.45%359.39%131.95%435.95%290.72%150.55%2149.80%633.49%1398.03%--
Enterprise Value
1,1421,9447317813843413079512117119
Last Close Price
1.212.281.641.731.301.181.361.070.821.160.74

Price Ratios

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Nov '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Forward PE
-5.085.085.085.085.085.085.085.085.085.08
PS Ratio
83.00141.2263.1364.3231.6328.7733.5921.0722.0670.297.49
PB Ratio
5.7310.805.004.812.362.131.960.890.601.230.13
P/TBV Ratio
6.3510.805.005.292.602.362.162.021.361.230.13
P/FCF Ratio
-----415.76---125.59-
P/OCF Ratio
---131.57111.09361.20---125.59-
PEG Ratio
-0.510.510.510.510.510.510.510.510.510.51

EV Ratios

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Nov '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
EV/Sales Ratio
83.15140.5650.9852.5925.9223.0526.4411.2422.2270.658.30
EV/FCF Ratio
-----333.10---126.24-

Financial Efficiency

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Nov '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Debt / Equity Ratio
0.010.010.010.010.010.010.010.030.030.010.01
Debt / FCF Ratio
-----2.04---1.48-
Net Debt / Equity Ratio
0.010.010.01-0.05-0.05-0.87-0.87-0.42-0.42-0.60-0.60
Net Debt / EBITDA Ratio
-1.35-1.35-1.436.205.6098.21-----
Net Debt / FCF Ratio
-0.17-0.17-0.020.050.11-170.28122.4121.8867.24-61.55510.82
Asset Turnover
0.070.070.070.070.070.080.070.070.050.03-
Inventory Turnover
70.9270.9273.1075.2376.1678.9660.9211.497.352.44-
Quick Ratio
0.170.170.171.191.1912.8312.837.507.5023.7023.70
Current Ratio
21.7721.7721.771.531.5314.2014.208.198.1939.5239.52
Return on Equity (ROE)
-9.85%-9.85%-40.76%-68.29%-68.10%-80.26%-42.09%-6.41%-7.63%-12.38%-
Return on Assets (ROA)
-1.24%-1.24%-1.36%-1.42%-1.29%-1.37%-1.89%-3.73%-4.21%-6.64%-
Return on Invested Capital (ROIC)
-2.18%-2.18%-2.37%-2.55%-4.08%-15.69%-7.65%-5.92%-9.05%-15.63%-40.75%
Return on Capital Employed (ROCE)
-2.20%-2.20%-2.40%-2.40%-2.20%-2.00%-2.70%-3.40%-3.90%-6.20%-9.00%

Yields

Fiscal Quarter
CurrentQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period Ending
Nov '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23
Earnings Yield
-2.26%-0.96%-8.53%-14.21%-28.89%-31.75%-18.14%-3.70%-6.69%-5.57%-43.49%
FCF Yield
-1.11%-0.66%-10.01%-17.64%-17.87%0.24%-0.36%-2.17%-1.05%0.80%-0.94%
Buyback Yield / Dilution
-153.50%-153.50%-55.24%-204.20%-257.10%-504.37%-1475.88%-565.82%-949.18%-106.30%-53.20%
Total Shareholder Return
-153.50%-153.50%-55.24%-204.20%-257.10%-504.37%-1475.88%-565.82%-949.18%-106.30%-53.20%
SEC Filings: 10-K · 10-Q